Next Article in Journal
Immune Checkpoint Inhibitors and Antibody-Drug Conjugates in Urothelial Carcinoma: Current Landscape and Future Directions
Next Article in Special Issue
Baseline Radiomics as a Prognostic Tool for Clinical Benefit from Immune Checkpoint Inhibition in Inoperable NSCLC Without Activating Mutations
Previous Article in Journal
Survival Benefits of GLP-1 Receptor Agonists in Patients with Neuroendocrine Neoplasms: A Large-Scale Propensity-Matched Cohort Study
Previous Article in Special Issue
Incidence and Prevalence of Bone Metastases in Different Solid Tumors Determined by Natural Language Processing of CT Reports
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cancers
Volume 17
Issue 9
10.3390/cancers17091595
Version Notes
cancers-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Article

Article Versions Notes

Cancers 2025, 17(9), 1595; https://doi.org/10.3390/cancers17091595
Action Date Notes Link
article pdf uploaded. 7 May 2025 16:24 CEST Version of Record https://www.mdpi.com/2072-6694/17/9/1595/pdf-vor
article pdf uploaded. 7 May 2025 16:27 CEST Updated version of record https://www.mdpi.com/2072-6694/17/9/1595/pdf-vor
article xml file uploaded 8 May 2025 12:05 CEST Original file -
article xml uploaded. 8 May 2025 12:05 CEST Update https://www.mdpi.com/2072-6694/17/9/1595/xml
article pdf uploaded. 8 May 2025 12:05 CEST Updated version of record https://www.mdpi.com/2072-6694/17/9/1595/pdf
article html file updated 8 May 2025 12:07 CEST Original file -
article html file updated 25 June 2025 03:26 CEST Update https://www.mdpi.com/2072-6694/17/9/1595/html
Back to TopTop